Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technological Advancements in Transfection
4.2.2 Increase in R&D Expenditure and Research Activities by Pharmaceutical and Biotech Companies
4.2.3 Rise in Demand for Synthetic Genes
4.3 Market Restraints
4.3.1 High Cost of Transfection Reagents
4.3.2 Selective Effectiveness and Certain Limitations of Transfection Reagents
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Reagents
5.1.2 Equipment
5.2 By Method
5.2.1 Biochemical Methods
5.2.2 Physical Methods
5.2.3 Viral Methods
5.3 By End User
5.3.1 Pharmaceutical & Biotechnology Companies
5.3.2 Academics & Research Institutes
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Rest of the World


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bio-Rad Laboratories
6.1.2 Lonza Group
6.1.3 MaxCyte Inc.
6.1.4 Merck KGaA
6.1.5 Mirus Bio
6.1.6 Polyplus-transfection SA
6.1.7 Promega Corporation
6.1.8 Qiagen N.V.
6.1.9 Thermo Fisher Scientific Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS